MedTrace Logo

Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX

NCT00590213 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2008-01-25

No results posted yet for this study

Summary

The primary objective of this trial is to examine the value of prophylactic versus therapeutic breast radiotherapy in Casodex monotherapy induced gynaecomastia and/or breast pain. Patients will receive either prophylactic radiotherapy to the breast at a dose of 12Gy (as two fractions of 6 Gy in consecutives days), or will not receive any radiotherapy prior to commencing CASODEX 150mg monotherapy.

Conditions

Interventions

DRUG

Casodex 150mg

PROCEDURE

Radiotherapy

PROCEDURE

Haematology

Sponsors & Collaborators

Principal Investigators

  • Haluk Ozen, Prof · Hacettepe Univ. Med. Fac

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590213 on ClinicalTrials.gov